DRUG · Mapped RxNorm record
Memantine
Normalized identity: memantineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease
NCT00646204
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNamenda (Memantine) for Non-motor Symptoms in Parkinson's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson's Diseaseverified · MONDO: Parkinson disease
Interventions
MemantineDRUG · verified · RxNorm: memantine
placeboDRUG
Sponsors & collaborators
Baylor College of Medicinelead sponsor
Forest Laboratoriescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00646204 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.